Howlader N NA, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ. SEER most cancers statistics evaluation. In: Ka C (ed). Bethesda: Nationwide Most cancers Institute. 1975–2016.
Weiss A, Chavez-MacGregor M, Lichtensztajn DY, Yi M, Tadros A, Hortobagyi GN, Giordano SH, Hunt KK, Mittendorf EA. Validation research of the american joint committee on most cancers eighth version prognostic stage in contrast with the anatomic stage in breast most cancers. JAMA Oncol. 2018;4:203–9. https://doi.org/10.1001/jamaoncol.2017.4298.
Group USCSW. U.S. Most cancers Statistics Knowledge Visualizations Instrument, primarily based on November 2018 submission knowledge (1999–2016). In: U.S. Division of Well being and Human Providers CfDCaPaNCI (ed). 2019.
Hennigs A, Riedel F, Gondos A, Sinn P, Schirmacher P, Marme F, Jager D, Kauczor HU, Stieber A, Lindel Okay, Debus J, Golatta M, Schutz F, Sohn C, Heil J, Schneeweiss A. Prognosis of breast most cancers molecular subtypes in routine medical care: a big potential cohort research. BMC Most cancers. 2016;16:734. https://doi.org/10.1186/s12885-016-2766-3.
Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, Kelly SP, Zaorsky NG. A population-based research of heart problems mortality danger in US most cancers sufferers. Eur Coronary heart J. 2019;40:3889–97. https://doi.org/10.1093/eurheartj/ehz766.
William M, Sikov JCB, Al-Hilli Z. Basic ideas of neoadjuvant administration of breast most cancers. In: Burstein HJ (ed) UpToDate. Waltham. 2020.
Schadler KL, Thomas NJ, Galie PA, Bhang DH, Roby KC, Addai P, Until JE, Sturgeon Okay, Zaslavsky A, Chen CS, Ryeom S. Tumor vessel normalization after cardio train enhances chemotherapeutic efficacy. Oncotarget. 2016. https://doi.org/10.18632/oncotarget.11748.
Betof AS, Lascola CD, Weitzel D, Landon C, Scarbrough PM, Devi GR, Palmer G, Jones LW, Dewhirst MW. Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by train. J Natl Most cancers Inst. 2015. https://doi.org/10.1093/jnci/djv040.
Sturgeon Okay, Schadler Okay, Muthukumaran G, Ding D, Bajulaiye A, Thomas NJ, Ferrari V, Ryeom S, Libonati JR. Concomitant low-dose doxorubicin therapy and train. Am J Physiol Regul Integr Comp Physiol. 2014;307:R685-692. https://doi.org/10.1152/ajpregu.00082.2014.
Khushhal A, Nichols S, Carroll S, Abt G, Ingle L. Inadequate train depth for medical profit? Monitoring and quantification of a community-based Part III cardiac rehabilitation programme: a United Kingdom perspective. PLoS ONE. 2019;14:e0217654. https://doi.org/10.1371/journal.pone.0217654.
Campbell KL, Winters-Stone KM, Wiskemann J, Might AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH. Train pointers for most cancers survivors: consensus assertion from worldwide multidisciplinary roundtable. Med Sci Sports activities Exe. 2019;51:2375–90. https://doi.org/10.1249/MSS.0000000000002116.
Schmitz KH, Campbell AM, Stuiver MM, Pinto BM, Schwartz AL, Morris GS, Ligibel JA, Cheville A, Galvao DA, Alfano CM, Patel AV, Hue T, Gerber LH, Sallis R, Gusani NJ, Stout NL, Chan L, Flowers F, Doyle C, Helmrich S, Bain W, Sokolof J, Winters-Stone KM, Campbell KL, Matthews CE. Train is drugs in oncology: partaking clinicians to assist sufferers transfer by means of most cancers. CA Most cancers J Clin. 2019;69:468–84. https://doi.org/10.3322/caac.21579.
Peel AB, Thomas SM, Dittus Okay, Jones LW, Lakoski SG. Cardiorespiratory health in breast most cancers sufferers: a name for normative values. J Am Coronary heart Assoc. 2014;3:e000432. https://doi.org/10.1161/JAHA.113.000432.
Lakoski SG, Barlow CE, Koelwyn GJ, Hornsby WE, Hernandez J, Defina LF, Radford NB, Thomas SM, Herndon JE 2nd, Peppercorn J, Douglas PS, Jones LW. The affect of adjuvant remedy on cardiorespiratory health in early-stage breast most cancers seven years after prognosis: the Cooper Middle Longitudinal Research. Breast Most cancers Res Deal with. 2013;138:909–16. https://doi.org/10.1007/s10549-013-2478-1.
Barlow CE, Defina LF, Radford NB, Berry JD, Cooper KH, Haskell WL, Jones LW, Lakoski SG. Cardiorespiratory health and long-term survival in “low-risk” adults. J Am Coronary heart Assoc. 2012;1:e001354. https://doi.org/10.1161/JAHA.112.001354.
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Train capability and mortality amongst males referred for train testing. N Engl J Med. 2002;346:793–801. https://doi.org/10.1056/NEJMoa011858.
Erikssen G, Liestol Okay, Bjornholt J, Thaulow E, Sandvik L, Erikssen J. Adjustments in bodily health and modifications in mortality. Lancet. 1998;352:759–62. https://doi.org/10.1016/S0140-6736(98)02268-5.
Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CN, Lauer MS, Marwick TH, Pandey DK, Wicklund RH, Thisted RA. The prognostic worth of a nomogram for train capability in girls. N Engl J Med. 2005;353:468–75. https://doi.org/10.1056/NEJMoa044154.
Jones LW, Liang Y, Pituskin EN, Battaglini CL, Scott JM, Hornsby WE, Haykowsky M. Impact of train coaching on peak oxygen consumption in sufferers with most cancers: a meta-analysis. Oncologist. 2011;16:112–20. https://doi.org/10.1634/theoncologist.2010-0197.
Roger VL, Jacobsen SJ, Pellikka PA, Miller TD, Bailey KR, Gersh BJ. Prognostic worth of treadmill train testing: a population-based research in Olmsted County, Minnesota. Circulation. 1998;98:2836–41.
Hornsby WE, Douglas PS, West MJ, Kenjale AA, Lane AR, Schwitzer ER, Ray KA, Herndon JE 2nd, Coan A, Gutierrez A, Hornsby KP, Hamilton E, Wilke LG, Kimmick GG, Peppercorn JM, Jones LW. Security and efficacy of cardio coaching in operable breast most cancers sufferers receiving neoadjuvant chemotherapy: a section II randomized trial. Acta Oncol. 2014;53:65–74. https://doi.org/10.3109/0284186X.2013.781673.
American School of Sports activities Drugs, Thompson WR, Gordon NF, Pescatello LS. ACSM’s pointers for train testing and prescription. Philadelphia: Lippincott Williams & Wilkins; 2010.
Tanaka H, Monahan KD, Seals DR. Age-predicted maximal coronary heart fee revisited. J Am Coll Cardiol. 2001;37:153–6. https://doi.org/10.1016/s0735-1097(00)01054-8.
Borg G, Dahlstrom H. A pilot research of perceived exertion and bodily working capability. Acta Soc Med Ups. 1962;67:21–7.
Amireault S, Godin G, Lacombe J, Sabiston CM. Using the Godin-Shephard Leisure-Time Bodily Exercise Questionnaire in oncology analysis: a scientific evaluation. BMC Med Res Methodol. 2015;15:60. https://doi.org/10.1186/s12874-015-0045-7.
Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a piece productiveness and exercise impairment instrument. Pharmacoeconomics. 1993;4:353–65. https://doi.org/10.2165/00019053-199304050-00006.
Stein KD, Jacobsen PB, Blanchard CM, Thors C. Additional validation of the multidimensional fatigue symptom inventory-short kind. J Ache Symptom Manag. 2004;27:14–23. https://doi.org/10.1016/j.jpainsymman.2003.06.003.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form well being survey (SF-36). I. Conceptual framework and merchandise choice. Med Care. 1992;30:473–83.
Warren M, Schmitz KH. Security of power coaching in premenopausal girls: musculoskeletal accidents from a two-year randomized trial. Am J Well being Promot AJHP. 2009;23:309–14. https://doi.org/10.4278/ajhp.07081584.
Schmitz KH, Williams NI, Kontos D, Kurzer MS, Schnall M, Domchek S, Stopfer J, Galantino ML, Hwang WT, Morales Okay, Wu S, DiGiovanni L, Salvatore D, Fenderson D, Good J, Sturgeon Okay, Grant L, Bryan CJ, Adelman J. Ladies In Regular Train Analysis (WISER) Sister: research design and strategies. Contemp Clin Trials. 2015;41:17–30. https://doi.org/10.1016/j.cct.2014.12.016.
Kirkham AA, Bland KA, Zucker DS, Bovard J, Shenkier T, McKenzie DC, Davis MK, Gelmon KA, Campbell KL. “Chemotherapy-periodized” train to accommodate for cyclical variation in fatigue. Med Sci Sports activities Exerc. 2020;52:278–86. https://doi.org/10.1249/MSS.0000000000002151.
Kirkham AA, Bonsignore A, Bland KA, McKenzie DC, Gelmon KA, Van Patten CL, Campbell KL. Train prescription and adherence for breast most cancers: one measurement doesn’t FITT all. Med Sci Sports activities Exerc. 2018;50:177–86. https://doi.org/10.1249/MSS.0000000000001446.
Huang HP, Wen FH, Tsai JC, Lin YC, Shun SC, Chang HK, Wang JS, Jane SW, Chen MC, Chen ML. Adherence to prescribed train time and depth declines because the train program proceeds: findings from girls below therapy for breast most cancers. Help Care Most cancers Off J Multinatl Assoc Help Care Most cancers. 2015;23:2061–71. https://doi.org/10.1007/s00520-014-2567-7.
Witlox L, Velthuis MJ, Boer JH, Steins Bisschop CN, Wall EV, Meulen W, Schroder CD, Peeters PHM, Might AM. Attendance and compliance with an train program throughout localized breast most cancers therapy in a randomized managed trial: the PACT research. PLoS ONE. 2019;14:e0215517. https://doi.org/10.1371/journal.pone.0215517.
Cornette T, Vincent F, Mandigout S, Antonini MT, Leobon S, Labrunie A, Venat L, Lavau-Denes S, Tubiana-Mathieu N. Results of home-based train coaching on VO2 in breast most cancers sufferers below adjuvant or neoadjuvant chemotherapy (SAPA): a randomized managed trial. Eur J Phys Rehabil Med. 2016;52:223–32.
van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, Hellendoorn-van Vreeswijk JA, Sonke GS, Aaronson NK. Impact of low-intensity bodily exercise and moderate- to high-intensity bodily train throughout adjuvant chemotherapy on bodily health, fatigue, and chemotherapy completion charges: outcomes of the PACES randomized medical trial. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33:1918–27. https://doi.org/10.1200/JCO.2014.59.1081.
Huang HP, Wen FH, Yang TY, Lin YC, Tsai JC, Shun SC, Jane SW, Chen ML. The impact of a 12-week home-based strolling program on lowering fatigue in girls with breast most cancers present process chemotherapy: a randomized managed research. Int J Nurs Stud. 2019;99: 103376. https://doi.org/10.1016/j.ijnurstu.2019.06.007.
Lee Okay, Kang I, Mack WJ, Mortimer J, Sattler F, Salem G, Dieli-Conwright CM. Feasibility of excessive depth interval coaching in sufferers with breast most cancers present process anthracycline chemotherapy: a randomized pilot trial. BMC Most cancers. 2019;19:653. https://doi.org/10.1186/s12885-019-5887-7.
Witlox L, Hiensch AE, Velthuis MJ, Steins Bisschop CN, Los M, Erdkamp FLG, Bloemendal HJ, Verhaar M, Ten Bokkel HD, van der Wall E, Peeters PHM, Might AM. 4-year results of train on fatigue and bodily exercise in sufferers with most cancers. BMC Med. 2018;16:86. https://doi.org/10.1186/s12916-018-1075-x.
Sturgeon KM, Fisher C, McShea G, Sullivan SK, Sataloff D, Schmitz KH. Affected person choice and timing for train in breast most cancers care. Help Care Most cancers Off J Multinatl Assoc Help Care Most cancers. 2018;26:507–14. https://doi.org/10.1007/s00520-017-3856-8.
Riedel F, Hoffmann AS, Moderow M, Heublein S, Deutsch TM, Golatta M, Wallwiener M, Schneeweiss A, Heil J, Hennigs A. Time tendencies of neoadjuvant chemotherapy for early breast most cancers. Int J Most cancers. 2020;147:3049–58. https://doi.org/10.1002/ijc.33122.
